Debate: TDF vs. TAF in HBV management | Mark Nelson, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Decrease in HCV Coinfection in Individuals Newly Diagnosed with HIV-1 in Germany, January 2016 - December 2017 | Patrycja Machnowska

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Characterization of Patients Treated with Hepatitis C - is HIV a Burden? Analysis of an Individual Experience | Cristina Valente

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Epidemiological Characteristics and Factors Contributing to the Development of Liver Fibrosis in HIV/HCV-Coinfected Patients in Ukraine | Tatyana Kyrychenko

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Hepatitis C Diagnostic - Barrier to Effective Linkage to Care within Georgian Hepatitis C Elimination Program | Guranda Jikia, MD, MPH

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HBV managment in HIV patients | Karine Lacombe, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HCV care after cure | Raffaele Bruno, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Fibrosis Markers and Cirrhosis management in HIV patients | Marion Peters, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

NAFLD: diagnostics, management and screening | Juan Macías, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Liver care in HIV - management of abnormal LFTs | Juan Berenguer, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HBV: diagnostics, management and screening | Marion Peters, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HCV in 2018 | Jürgen Rockstroh, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Prevalence of Hepatitis B Virus and Vaccine Antibody Titers Among HIV Positive and Negative Infants in Botswana - Lynnette N. Bhebhe

Conference on Liver Disease in Africa (COLDA) 2020

Variceal Recurrence 4 years beyond Endoscopic Band Ligationin Hepatitis C Patients who Achieved Sustained Virological Response Post Direct Acting Antiviral Therapies - Mohamed Abdel-Samiee

Conference on Liver Disease in Africa (COLDA) 2020

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HBV: diagnostics, management and screening- Marion Peters, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Liver care in HIV - management of abnormal LFTs- Juan Berenguer, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HCV in 2018- Jürgen Rockstroh, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

NAFLD: diagnostics, management and screening- Juan Macías, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Fibrosis Markers and Cirrhosis management in HIV patients | Marion Peters, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Response to Sofosbuvir/Ledipasvir for 8 or 12 Weeks in HCV-Monoinfected and HIV/HCV-Coinfected Patients in Clinical Practice | Anaïs Corma

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Real-life Results of Grazoprevir/Elbasvir in HCV-Infected PWID: The Zepalive Studi | Juan Macías

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Baseline Resistance-Guided Therapy Does Not Enhance the Response to Interferon-Free Treatment of HCV Infection in Real Life | Luis M. Real

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HCV care after cure- Raffaele Bruno, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018